Xeris Bi

Xeris Biopharma Reports Strong Fourth-Quarter Results

Xeris Biopharma Holdings, Inc., headquartered in Chicago, announced a net profit of $11.1 million for the fourth quarter.

Earnings per share reached 6 cents, exceeding the company's earlier projections.

These results outperformed analyst expectations, as a consensus of four analysts polled by Zacks Investment Research had anticipated earnings of 3 cents per share.

Quarterly revenue totaled $85.8 million, surpassing the $81.4 million forecasted by analysts surveyed by Zacks.

For the entire year, Xeris Biopharma recorded a profit of $554,000 and reported annual revenue of $291.8 million.

Looking ahead, the company anticipates full-year revenue to fall between $375 million and $390 million.

Report generated by Automated Insights using data from Zacks Investment Research.